| |
| | Prince George |
 | | Bali P., George P., Tao, J., Guo, F., Sigua, C., Vishvanath, A., Moscinski, L., Cohen, P., Atadja, P and Bhalla K. A combination of histone deacetylase inhibitor LAQ824 and the FLT-3 kinase inhibitor PKC412 is highly active against human AML cells with constitutively active mutant FLT-3 tyrosine kinase. |
 | | Gutti R., George P., Bali P., Tao J., Guo F., Sigua C., Li Y., Moscinski L., Atadja P and Bhalla K. A combination of histone deacetylase inhibitor LBH589 and the hsp90 inhibitor 17-AAG is highly active against human CML-BC and AML cells with constitutively active mutant FLT-3 tyrosine kinase. |
 | | Bhalla K., George P., Gutti R., Bali P., Tao J., Guo F., Sigua C., Li Y., Cohen P and Atadja, P. A combination of histone deacetylase inhibitor LBH589 and the hsp90 inhibitor 17-AAG is highly active against human CML-BC and AML cells with constitutively active mutant FLT-3 tyrosine kinase. |
| www.bi.ku.dk /staff/person.asp?ID=386 (573 words) |
|